×

Method for quantifying lipopolysaccharide binding protein

  • US 5,484,705 A
  • Filed: 01/24/1994
  • Issued: 01/16/1996
  • Est. Priority Date: 01/24/1994
  • Status: Expired due to Term
First Claim
Patent Images

1. A method for screening for gram-negative bacterial endotoxin involvement in an acute phase response in humans comprising:

  • (a) contacting a blood sample from a subject exhibiting an acute phase response with a specific binding partner for lipopolysaccharide binding protein,(b) determining the level of lipopolysaccharide binding protein in said blood sample, and(c) comparing the level of lipopolysaccharide binding protein determined in step (b) to levels of lipopolysaccharide binding protein in blood circulation in normal subjects, elevated levels of lipopolysaccharide binding protein being indicative of an acute phase response involving gram-negative bacterial endotoxin.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×